Near-infrared spectroscopy (NIRS)-obtained muscle oxygenation data at baseline, 50 W, and the ventilatory threshold (VT). by Austin K. Ederer (848527)

Benchmarking DEWÄKSS on a predefined benchmark test [29]. by Andreas Tjärnberg (3438332)

Effect of OP2113 on infarct size. by Dominique Detaille (3768979)

Decreased PGC-1α expression is associated with a hyperglycemia-induced increase in mitochondrial fragmentation and ROS generation. by Kaifeng Guo (296791)

Fluorescent intensity at 520 nm (RNase A/B) and 556 nm (DNase I) versus time for nucleases in DI water lysed with Lyse-It at 30% and 50% power for varying time. by Tonya M. Santaus (5559077)

Decreased <i>Pax2</i> expression in <i>p53^−/−</i> embryonic kidneys. by Zubaida Saifudeen (135684)

“…<b>B</b>) In situ hybridization. Decreased expression of <i>Pax2</i> mRNA at E12.5. …”

TGF-β1 treatment decreased RELN transcriptional activity, but did not affect RELN mRNA stability. by Yi Yuan (180239)

Image2_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIF by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

Image1_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIFF by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

Image3_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIF by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

TGF-β1 decreases RECK levels through a Smad and JNK dependent <i>pathway</i>. by Jaime Gutiérrez (401710)

Decrease of IL-6 and increase of IL-10 secretion in HESN derived-neutrophils after TLR4 stimulation. by Juan C. Hernandez (704571)

Parasite invasion and acute virulence were reduced in the Δ<i>crt</i> parasites. by L. Brock Thornton (6808385)

Elementary trends on the time series for the prices of the DJIA during the period from Oct/30/1978 to Jan/09/1979. by Héctor Raúl Olivares-Sánchez (13014866)

Tgfβ and p53 response in the SDS pancreas. by Marina E. Tourlakis (751986)

“…<p><b>A,</b> Steady state protein levels paralleled observed transcript changes with decreased Myc and increased p21^Cip and Tgfβ expression, along with changes in Smad2 and Smad3 phosphorylation status in mutants. …”

OP2113 improves the recovery of the contractile performance of Langendorff-perfused rat heart during the reperfusion phase following ischemia. by Dominique Detaille (3768979)

The effect of repeating k-means clustering ten times is presented with respect to the change in cluster allocation and the respective mean Silhouette value. by Gregor Kuntze (5892437)

Photographs of cross-sections of cotton balls and fiber tissues harvested at different days post anthesis (DPA), showing the expression patterns of reporter gene activities in C22... by Junping Chen (182808)

The inhibitory effects of rosiglitazone and pioglitazone on the formation of functional osteoclasts on bone slices are significantly decreased in RANKL-pretreated BMMs. by Dongfeng Zhao (258868)

Mean maximum insertion forces by speed and lubrication. by Max Fröhlich (17841416)